A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...

Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...

New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...

New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.

Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its ...

Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...

New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for insider trading.

GAITHERSBURG, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration ...

Johnson & Johnson and Emergent BioSolutions pointed blame at each other June 6 for breaking agreements in a COVID-19 vaccine supply contract, according to the Wall Street Journal. Emergent ...

GAITHERSBURG, Md., June 23, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a $62.4 million contract modification from the Administration for ...